SEC Tracker
Get the app

Adial Pharmaceuticals AZR

Adial Pharmaceuticals names new CEO and CFO

Item 5.02 Executive or director change, Item 5.03 Amends charter or bylaws, Item 5.07 Shareholder vote results

Form
8-K
Filed
Importance
Major
  1. Matthew Davidson appointed as CEO and President
  2. Celia Economides appointed as CFO
  3. Julie Saiki appointed as Chief Strategy Officer

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Adial Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. AIM ImmunoTech AIM public float $6M, Jun 30, 2025
  2. Vyome Holdings HIND public float $6M, Jun 30, 2025
  3. Biomerica BMRA public float $7M, Nov 28, 2025
  4. Protagenic Therapeutics, Inc.\new PTIX public float $7M, Sep 30, 2025
  5. PharmaCyte Biotech PMCB public float $6M, Oct 31, 2025